PMAM
Picton Mahoney Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63
| Closed | -$4K | – | 1010 |
|
|
2025
Q1 | $4K | Buy |
+63
| New | +$4K | ﹤0.01% | 625 |
|
|
2022
Q4 | – | Sell |
-71,663
| Closed | -$5.92M | – | 680 |
|
|
2022
Q3 | $5.92M | Buy |
71,663
+38,800
| +118% | +$3.21M | 0.21% | 88 |
|
|
2022
Q2 | $3.13M | Buy |
32,863
+40
| +0.1% | +$3.81K | 0.12% | 222 |
|
|
2022
Q1 | $3.87M | Sell |
32,823
-1,477
| -4% | -$174K | 0.14% | 195 |
|
|
2021
Q4 | $4.44M | Buy |
+34,300
| New | +$4.44M | 0.11% | 141 |
|
|
2021
Q1 | – | Sell |
-151,541
| Closed | -$13.8M | – | 344 |
|
|
2020
Q4 | $13.8M | Sell |
151,541
-2,114
| -1% | -$193K | 0.66% | 37 |
|
|
2020
Q3 | $12.3M | Sell |
153,655
-14,185
| -8% | -$1.13M | 0.68% | 42 |
|
|
2020
Q2 | $11.6M | Buy |
+167,840
| New | +$11.6M | 0.67% | 47 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 182 |
|
|
2017
Q3 | – | Sell |
-247,747
| Closed | -$29.3M | – | 177 |
|
|
2017
Q2 | $29.3M | Sell |
247,747
-56,800
| -19% | -$6.72M | 2.09% | 3 |
|
|
2017
Q1 | $28.7M | Buy |
304,547
+2,150
| +0.7% | +$202K | 1.92% | 3 |
|
|
2016
Q4 | $28.3M | Sell |
302,397
-127,053
| -30% | -$11.9M | 2.33% | 2 |
|
|
2016
Q3 | $51.8M | Buy |
429,450
+13,800
| +3% | +$1.66M | 3.47% | 1 |
|
|
2016
Q2 | $41.5M | Sell |
415,650
-19,300
| -4% | -$1.92M | 2.55% | 2 |
|
|
2016
Q1 | $38.4M | Buy |
434,950
+245,050
| +129% | +$21.6M | 2.46% | 2 |
|
|
2015
Q4 | $15M | Buy |
+189,900
| New | +$15M | 0.9% | 34 |
|